Back PhD projects

PhD projects

Interested? Reach out to supervisors to ask about a project, or to GenV’s Student Coordinator for general enquiries about GenV PhD projects.

Why are babies in SCNs/NICUs at higher risk of permanent hearing loss?

Why are babies in SCNs/NICUs at higher risk of permanent hearing loss?

Project description:

This PhD offers potential for practice changes that could improve lifelong hearing for infants admitted to SCNs/NICUs. Supervised by leading researchers in children’s hearing loss, epidemiology, paediatrics and audiology, it offers immense opportunities to establish a career and leadership in transformative newborn and child hearing loss research within the GenV initiative and beyond. 

Around one in five liveborn babies require admission to a special care nursery (SCN) or neonatal care unit (NICU). Admission to SCN/NICU is a known risk factor for permanent hearing loss. Compared to healthy babies, those admitted to NICUs are at 8 times the risk of hearing loss, with many hypothesized and interacting causal factors including immaturity, anaemia, infection/inflammation, ototoxic drugs, environmental noise, jaundice, intracranial haemorrhage/encephalopathy, hypoxia and genetic susceptibility. Large sample sizes and variations in care that equate to natural experiments are needed to clarify causal pathways and thence effective prevention and treatment. 

This PhD project will be conducted within the ‘Generation Victoria’ cohort, the only mega-birth cohort now recruiting internationally, targeting all 150,000 Victorian births over two years from 2021 and encompassing Victoria’s 5 NICUs and 40 SCNs. You will help set up a new statewide SCN data registry within GenV within which you will study critical SCN/NICU causal to hearing loss, including objective measurement of noise in each SCN/NICU. 

Supervisors: A/Prof Valerie Sung, Dr Jing Wang, Dr Peter Carew, Prof Melissa Wake 

Use and impact of psychotropic medication in pregnancy

Use and impact of psychotropic medication in pregnancy

Project description: Up to 20% of women suffer from mood or anxiety disorders during pregnancy, whose impacts on adverse pregnancy and child outcomes could be mitigated by antenatal psychotropic medications (such as antidepressants, antipsychotics, sedative-hypnotics and other sleep medications). While these medications appear safe in pregnancy, the knowledge base is incomplete, so some mothers choose against needed medication due to fear it may affect their unborn baby. This PhD student will work within the landmark ‘Generation Victoria’ (GenV) cohort, targeting all 150,000 babies born over two years (Oct 2021-Oct 2023) and their mothers at all 58 birthing hospitals in the state of Victoria, comprising consent, biosamples, and wide-ranging exposures and outcomes including administrative and clinical data. The student will contribute to creating a unique whole-state prescribing dataset within GenV by linkage/access to both primary care/outpatient medicines (Pharmaceutical Benefits Scheme (PBS)) and birthing hospitals prescribing data during pregnancy and the perinatal period. They will map ante/perinatal psychotropic medication use in the GenV cohort and then use causal techniques (including consideration of regional variations in medication use) to assess impacts on perinatal and infant/toddler outcomes such as language development, fine motor skills, and body composition. 

Supervisors: Prof Melissa Wake, Dr Jessika Hu, Prof Peter Coghill

Do we have sufficient safe medicine use information for pregnant women and their offspring?

Do we have sufficient safe medicine use information for pregnant women and their offspring?

Project description: The environments in which we live, work and play impact our health. It is also likely that the neighbourhood environments that parents are exposed to during preconception and pregnancy have lifelong health impacts. Studies have shown that exposure to air pollution in pregnancy is linked to a range of negative health effects at birth and in later life. However, we don’t yet know: 1) whether preconception exposures to neighbourhood environments are linked to health; 2) how parental exposures to other aspects of the neighbourhood environment such as greenspace, noise and access to services influence health; or 3) how different aspects of the neighbourhood interact, for example, does living in a greener neighbourhood offset the negative effects of air pollution?

This PhD project will address these knowledge gaps by investigating the relationship between different aspects of the neighbourhood that parents were exposed to prior to birth and health outcomes in the early years of life. The project will use data from the Generation Victoria (GenV) cohort, which has collected parents’ residential address data and has information on child health. Multiple measures of the neighbourhood will be developed using geospatial data and methods (e.g., geographic information systems and remote sensing). These measures will be linked to GenV participant addresses, and statistical analyses will be used to investigate the relationship between parental exposures prior to birth and child health (e.g., preterm birth, child development). Findings from the PhD will inform environmental interventions via urban planning and design.

This project will suit a researcher with strong quantitative skills, an interest in geography and neighbourhood environments, and a willingness to learn geospatial skills.

Supervisors: A/Prof Suzanne Mavoa, Prof Melissa Wake 

Neighbourhood environment exposures prior to birth and child health and development in the early years

Neighbourhood environment exposures prior to birth and child health and development in the early years

Project description: help children flourish, prevent illness and effectively manage the problems of the 21st century such as autism, obesity and depression. Yet children are underserved in interventional research and especially in large trials aligned with children’s highest-burden problems. Conversely, children are well-represented in large cohorts that capture today’s complex, interconnected challenges and outcomes, but these cohorts are not driving solutions at the scale needed.

Generation Victoria (GenV) is recruiting large, parallel whole-of-state cohorts of children born 2021-2023 and their parents to help find solutions to complex problems facing children and adults today. Alone among mega-cohorts internationally, GenV is now planning its Intervention Hub. The Hub will utilise the power of GenV to develop an intervention pipeline that can improve the health and wellbeing of our children and our nation. This will support many trials and trial designs, to show which policies, services and discoveries can really change outcomes at scale.

Expressions of interest are sought from prospective PhD students who wish to develop and conduct an embedded trial in GenV’s early childhood window. Interventions must be feasible to implement at a population level (whether targeted or universal) and align with a high-burden issue of global importance, such as mental health, climate and environment, cognition, development and educational outcomes, or health issues such as obesity, allergies and infections.

This PhD is not specific to any discipline and may appeal equally to clinician-scientists or research-only pathways. A commitment to rigorous evidence is essential.

Supervisors: Prof Melissa Wake, Dr Suzanne Long

PhDs within the Generation Victoria (GenV) program

PhDs within the Generation Victoria (GenV) program

Interested in a PhD with Generation Victoria (GenV), Australia’s largest and most inclusive children’s and pre-midlife cohort? Make cutting-edge discoveries or test new interventions to help young children and adults flourish and manage 21st-century challenges. Contact a GenV Director to discuss. 

The GenV cohorts, an international asset led from Victoria (population 6.8m), Australia, include 120,000+ young children and parents representing Victoria’s birthing population. It comprises a consented cohort, linked data, universal biosamples, GenV-collected data, collaborator-led studies and an Open Science platform, offering access far beyond a stand-alone PhD. 

With its establishment phase complete and building blocks emerging, now is the perfect time for a PhD in GenV as children approach school age and parents approach mid-life. Explore discovery, effectiveness or policy questions through trials, natural experiments and causal epidemiology. GenV also supports PhD opportunities in -omics bioassays, data science, AI, ecological and linkage data, universal-capable measurement technology, and implementation science. We look forward to developing projects with high-potential students, placed with senior and early career supervisors tailored to need. 

While stipends and/or top-up scholarships may sometimes be available, students generally need to attract scholarship stipends for these PhDs. 

Supervisors: Prof Melissa Wake, Prof Sharon Goldfeld, Prof Richard Saffery. (We will help match successful students with supervisors.)